Records containing: Neoplasms
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2018-07-10Impact of Rosuvastatin on Risk Markers of Venous Thromboembolism During Systemic Therapy for Advanced Cancer
-
CLINICAL_TRIALS study record update · 2018-07-05A Pilot Study of EZN-2968, an Antisense Oligonucleotide Inhibitor of HIF-1alpha, in Adults With Advance Solid Tumors
-
CLINICAL_TRIALS study record update · 2018-07-05A Phase I Combination Study of AZD2281 and Cisplatin Plus Gemcitabine in Adults With Solid Tumors
-
CLINICAL_TRIALS study record update · 2018-06-26Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP Study
-
CLINICAL_TRIALS study record update · 2018-06-14Phase 1 Double-Blind, Placebo Controlled, Dose-Escalation Safety, Pharmacokinetic and Pharmacodynamic Study of Orally-Administered AMXT 1501 Dicaprate in Normal Healthy Volunteers
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2018-06-11Effectiveness of an Integrated Experiential Training Program With Coaching by Nursing Students in Promoting Regular Physical Activity and Reducing Fatigue Among Childhood Cancer Patients
-
CLINICAL_TRIALS study record update · 2018-06-04An Open Label, Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BAY94-9343 Given by Intravenous Infusion Every 3 Weeks (Q3W) in Japanese Subjects With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2018-05-22An Open-Label, Multicenter, Dose-Escalation Phase Ib Study With Expansion Phase to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Therapeutic Activity of Emactuzumab and RO7009789 Administered in Combination in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2018-05-16A Phase 1b/2 Study With Gemcitabine and LY2157299 for Patients With Metastatic Cancer (Phase 1b) and Advanced or Metastatic Unresectable Pancreatic Cancer (Phase 2)
-
CLINICAL_TRIALS study record update · 2018-05-11Safety, Feasibility and Cost-effectiveness of Genotype-directed Individualized Dosing of Fluoropyrimidines
-
CLINICAL_TRIALS study record update · 2018-04-30A Phase l/ll, Open Label, Dose-escalation Study of Varlilumab (CDX-1127) in Combination With Atezolizumab (MPDL3280A, Anti-PD-L1) in Patients With Advanced Cancer
-
CLINICAL_TRIALS study record update · 2018-04-20Biomarkers of Tumor Response in Hypofractionated Radiotherapy
-
CLINICAL_TRIALS study record update · 2018-04-18An Open Label, Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BAY 1163877 in Japanese Subjects With Refractory, Locally Advanced or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2018-04-10Phase 3b, Randomized Trial of Continuous Revlimid® (Lenalidomide) Therapy Versus Observation Following Induction Therapy That Does Not Include Revlimid, Pomalyst® or Thalomid® in Newly Diagnosed Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2018-04-06Randomized Study Comparing Two Strategies of Physical Activity in Long-term Breast and Colon Cancer Survivors and Their Impact on Fatigue
-
CLINICAL_TRIALS study record update · 2018-04-06Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease
-
CLINICAL_TRIALS study record update · 2018-04-05Interdisciplinary Rehabilitation of Patients With Glioma During Anti-cancer Treatment
-
CLINICAL_TRIALS study record update · 2018-04-04An Open-Label, Multicenter, Dose-Escalation Phase I Study of RO6874813, Administered Intravenously in Patients With Locally Advanced or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2018-03-27Community-Led Action Research in Oncology: Improving Symptom Management
-
CLINICAL_TRIALS study record update · 2018-03-20A Pilot and Feasibility Study of Intraoperative Imagery of Solid Tumors With Indocyanine Green
-
CLINICAL_TRIALS study record update · 2018-03-20A Pilot & Feasibility Study of the Imaging Potential of Indocyanine Green in Subjects Undergoing Minimally Invasive Thoracic Surgery Presenting With Thoracic Nodules
-
CLINICAL_TRIALS study record update · 2018-03-14Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients
-
CLINICAL_TRIALS study record update · 2018-03-06An Open-Label, Multi-Center, Dose-Escalation, Phase I Study With an Expansion Phase, to Evaluate Safety, Pharmacokinetics and Therapeutic Activity of RO6895882, an Immunocytokine, Consisting of a Variant of Interleukin-2 (IL-2v) Targeting Carcinoembryonic Antigen (CEA) Administered Intravenously, in Patients With Advanced and/or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2018-03-01The Effect of Resistance Training and Aerobic Training on Body Composition During Chemotherapy
-
CLINICAL_TRIALS study record update · 2018-02-26A Phase 1 Study Of Neratinib In Combination With Temsirolimus In Subjects With Solid Tumors